Dynamic quantification of host Schwann cell migration into peripheral nerve allografts

Experimental Neurology

Volumn 225, Issue 2, 2010, Pages 310-319

  Whitlock, Elizabeth L ^a   Myckatyn, Terence M ^a   Tong, Alice Y ^a   Yee, Andrew ^a   Yan, Ying ^a   Magill, Christina K ^a   Johnson, Philip J ^a   Mackinnon, Susan E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Composite tissue allotransplantation; Costimulation blockade; FK 506; Immunomodulation; Immunosuppression; Nerve allograft; Nerve transplantation; Tacrolimus

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE COSTIMULATION ANTIBODY; PROTEIN S 100; TACROLIMUS; UNCLASSIFIED DRUG; CASPASE 3; CD40 ANTIGEN; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; DRUG CHOICE; ENGRAFTMENT; GRAFT REJECTION; HOST CELL; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NERVE GRAFT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHWANN CELL; SCIATIC NERVE; T LYMPHOCYTE; WILD TYPE; ANALYSIS OF VARIANCE; ANIMAL; CELL MOTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; NERVE REGENERATION; PHYSIOLOGY; PROCEDURES; TRANSGENIC MOUSE; TRANSPLANTATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; BLOTTING, WESTERN; CASPASE 3; CELL MOVEMENT; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, TRANSGENIC; NERVE REGENERATION; S100 PROTEINS; SCHWANN CELLS; SCIATIC NERVE; TACROLIMUS;

EID: 77956446775     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.07.001     Document Type: Article

References (46)

1. Adami J., Gabel H., Lindelof B., Ekstrom K., Rydh B., Glimelius B., Ekbom A., Adami H.O., Granath F. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br. J. Cancer 2003, 89:1221-1227.
2. Ansselin A.D., Pollard J.D. Immunopathological factors in peripheral nerve allograft rejection: quantification of lymphocyte invasion and major histocompatibility complex expression. J. Neurol. Sci. 1990, 96:75-88.
3. Brenner M.J., Tung T.H., Mackinnon S.E., Myckatyn T.M., Hunter D.A., Mohanakumar T. Anti-CD40 ligand monoclonal antibody induces a permissive state, but not tolerance, for murine peripheral nerve allografts. Exp. Neurol. 2004, 186:59-69.
4. Brenner M.J., Jensen J.N., Lowe J.B., 3rd, Myckatyn T.M., Fox I.K., Hunter D.A., Mohanakumar T., Mackinnon S.E. Anti-CD40 ligand antibody permits regeneration through peripheral nerve allografts in a nonhuman primate model. Plast Reconstr Surg 2004, 114:1802-1814. discussion 1815-1807.
5. Devauchelle B., Badet L., Lengele B., Morelon E., Testelin S., Michallet M., D'Hauthuille C., Dubernard J.M. First human face allograft: early report. Lancet 2006, 368:203-209.
6. Doolabh V.B., Mackinnon S.E. FK506 accelerates functional recovery following nerve grafting in a rat model. Plast. Reconstr. Surg. 1999, 103:1928-1936.
7. Feng F.Y., Ogden M.A., Myckatyn T.M., Grand A.G., Jensen J.N., Hunter D.A., Mackinnon S.E. FK506 rescues peripheral nerve allografts in acute rejection. J. Neurotrauma 2001, 18:217-229.
8. Feske S., Giltnane J., Dolmetsch R., Staudt L.M., Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat. Immunol. 2001, 2:316-324.
9. Fox I.K., Mackinnon S.E. Experience with nerve allograft transplantation. Semin. Plast. Surg. 2007, 21:242-249.
10. Gold B.G., Katoh K., Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 1995, 15:7509-7516.
11. Grand A.G., Myckatyn T.M., Mackinnon S.E., Hunter D.A. Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J. Neurosurg. 2002, 96:924-932.
12. Guo L., Li X.K., Funeshima N., Fujino M., Nagata Y., Kimura H., Amemiya H., Enosawa S., Tsuji T., Harihara Y., Makuuchi M., Suzuki S. Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS). Transplantation 2002, 73:1027-1032.
13. Hayashi A., Koob J.W., Liu D.Z., Tong A.Y., Hunter D.A., Parsadanian A., Mackinnon S.E., Myckatyn T.M. A double-transgenic mouse used to track migrating Schwann cells and regenerating axons following engraftment of injured nerves. Exp. Neurol. 2007, 207:128-138.
14. Hayashi A., Moradzadeh A., Tong A., Wei C., Tuffaha S.H., Hunter D.A., Tung T.H., Parsadanian A., Mackinnon S.E., Myckatyn T.M. Treatment modality affects allograft-derived Schwann cell phenotype and myelinating capacity. Exp. Neurol. 2008, 212:324-336.
15. Hayashi A., Moradzadeh A., Tong A.Y., Wei C., Tuffaha S.H., Hunter D., Tung T.H., Parsadanian A., Mackinnon S.E., Myckatyn T.M. Treatment modality affects allograft-derived Schwann cell phenotype and myelinating capacity. Exp. Neurol. 2008.
16. Jensen J.N., Mackinnon S.E. Composite tissue allotransplantation: a comprehensive review of the literature-part 1. J. Reconstr. Microsurg. 2000, 16:57-68.
17. Jensen J.N., Mackinnon S.E. Composite tissue allotransplantation: a comprehensive review of the literature-Part II. J. Reconstr. Microsurg. 2000, 16:141-157.
18. Jensen J.N., Mackinnon S.E. Composite tissue allotransplantation: a comprehensive review of the literature-part III. J. Reconstr. Microsurg. 2000, 16:235-251.
19. Jost S.C., Doolabh V.B., Mackinnon S.E., Lee M., Hunter D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor. Neurol. Neurosci. 2000, 17:39-44.
20. Kang H., Tian L., Son Y.J., Zuo Y., Procaccino D., Love F., Hayworth C., Trachtenberg J., Mikesh M., Sutton L., Ponomareva O., Mignone J., Enikolopov G., Rimer M., Thompson W. Regulation of the intermediate filament protein nestin at rodent neuromuscular junctions by innervation and activity. J. Neurosci. 2007, 27:5948-5957.
21. Katsube K., Doi K., Fukumoto T., Fujikura Y., Shigetomi M., Kawai S. Successful nerve regeneration and persistence of donor cells after a limited course of immunosuppression in rat peripheral nerve allografts. Transplantation 1998, 66:772-777.
22. Kirk A.D., Harlan D.M., Armstrong N.N., Davis T.A., Dong Y., Gray G.S., Hong X., Thomas D., Fechner J.H., Knechtle S.J. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl Acad. Sci. USA 1997, 94:8789-8794.
23. Larsen C.P., Elwood E.T., Alexander D.Z., Ritchie S.C., Hendrix R., Tucker-Burden C., Cho H.R., Aruffo A., Hollenbaugh D., Linsley P.S., Winn K.J., Pearson T.C. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996, 381:434-438.
24. Lassner F., Schaller E., Steinhoff G., Wonigeit K., Walter G.F., Berger A. Cellular mechanisms of rejection and regeneration in peripheral nerve allografts. Transplantation 1989, 48:386-392.
25. Mackinnon S.E., Midha R., Bain J., Hunter D., Wade J. An assessment of regeneration across peripheral nerve allografts in rats receiving short courses of cyclosporin A immunosuppression. Neuroscience 1992, 46:585-593.
26. Mackinnon S.E., Doolabh V.B., Novak C.B., Trulock E.P. Clinical outcome following nerve allograft transplantation. Plast. Reconstr. Surg. 2001, 107:1419-1429.
27. Magott-Procelewska M. Costimulatory pathways as a basic mechanisms of activating a tolerance signal in T cells. Ann. Transplant. 2004, 9:13-18.
28. Midha R., Mackinnon S.E., Evans P.J., Best T.J., Hare G.M., Hunter D.A., Falk-Wade J.A. Comparison of regeneration across nerve allografts with temporary or continuous cyclosporin A immunosuppression. J. Neurosurg. 1993, 78:90-100.
29. Midha R., Mackinnon S.E., Becker L.E. The fate of Schwann cells in peripheral nerve allografts. J. Neuropathol. Exp. Neurol. 1994, 53:316-322.
30. Moore A.M., Ray W.Z., Chenard K.E., Tung T., Mackinnon S.E. Nerve allotransplantation as it pertains to composite tissue transplantation. Hand N.Y. 2009, 4:239-244.
31. Morris P.J., Bradley J.A., Doyal L., Earley M., Hagan P., Milling M., Rumsey N. Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation 2004, 77:330-338.
32. Nanji S.A., Hancock W.W., Anderson C.C., Adams A.B., Luo B., Schur C.D., Pawlick R.L., Wang L., Coyle A.J., Larsen C.P., Shapiro A.M. Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am. J. Transplant. 2004, 4:526-536.
33. Noble J., Munro C.A., Prasad V.S., Midha R. Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J. Trauma 1998, 45:116-122.
34. Ozkaynak E., Gao W., Shemmeri N., Wang C., Gutierrez-Ramos J.C., Amaral J., Qin S., Rottman J.B., Coyle A.J., Hancock W.W. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat. Immunol. 2001, 2:591-596.
35. Ray W.Z., Kasukurthi R., Papp E.M., Moore A.M., Yee A., Hunter D.A., Solowski N.L., Mohanakumar T., Mackinnon S.E., Tung T.H. The role of T helper cell differentiation in promoting nerve allograft survival with costimulation blockade. J. Neurosurg. 2009.
36. Salama A.D., Womer K.L., Sayegh M.H. Clinical transplantation tolerance: many rivers to cross. J. Immunol. 2007, 178:5419-5423.
37. Schaffer M.R., Fuchs N., Proksch B., Bongartz M., Beiter T., Becker H.D. Tacrolimus impairs wound healing: a possible role of decreased nitric oxide synthesis. Transplantation 1998, 65:813-818.
38. Udina E., Gold B.G., Navarro X. Comparison of continuous and discontinuous FK506 administration on autograft or allograft repair of sciatic nerve resection. Muscle Nerve 2004, 29:812-822.
39. Wang M.S., Zeleny-Pooley M., Gold B.G. Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J. Pharmacol. Exp. Ther. 1997, 282:1084-1093.
40. Whitlock E.L., Tuffaha S.H., Luciano J.P., Yan Y., Hunter D.A., Magill C.K., Moore A.M., Tong A.Y., Mackinnon S.E., Borschel G.H. Processed allografts and type I collagen conduits for repair of peripheral nerve gaps. Muscle Nerve 2009, 39:787-799.
41. Whitlock E.L., Kasukurthi R., Yan Y., Tung T.H., Hunter D.A., Mackinnon S.E. Fibrin glue mitigates the learning curve of microneurosurgical repair. Microsurgery 2010, 30:218-222.
42. Yang R.K., Lowe J.B., Sobol J.B., Sen S.K., Hunter D.A., Mackinnon S.E. Dose-dependent effects of FK506 on neuroregeneration in a rat model. Plast. Reconstr. Surg. 2003, 112:1832-1840.
43. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T., Tafuri-Bladt A., Brankow D., Campbell P., Chang D., Chiu L., Dai T., Duncan G., Elliott G.S., Hui A., McCabe S.M., Scully S., Shahinian A., Shaklee C.L., Van G., Mak T.W., Senaldi G. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999, 402:827-832.
44. Zalewski A.A., Gulati A.K. Survival of nerve and Schwann cells in allografts after cyclosporin A treatment. Exp. Neurol. 1980, 70:219-225.
45. Zhang Q.W., Rabant M., Schenk A., Valujskikh A. ICOS-dependent and -independent functions of memory CD4 T cells in allograft rejection. Am. J. Transplant. 2008, 8:497-506.
46. Zuo Y., Lubischer J.L., Kang H., Tian L., Mikesh M., Marks A., Scofield V.L., Maika S., Newman C., Krieg P., Thompson W.J. Fluorescent proteins expressed in mouse transgenic lines mark subsets of glia, neurons, macrophages, and dendritic cells for vital examination. J. Neurosci. 2004, 24:10999-11009.